《大行報告》花旗對北控(00392.HK)開展90天負面催化劑觀察期 目標價下調至33元
花旗發表研究報告指,對北控(00392.HK)開展90天負面催化劑觀察期,預計自明年1月1日起,其持有的40%陝西至北京中游管道的輸氣費將下調10%,將明年純利預測下調8%,2025年則下調7%。目標價下調8%,由36元降至33元,維持「買入」評級。
該行表示,預計集團今年管道利潤將按年增長18%,與上半年的水平相近,這主要是受到銷售增長所帶動,不過部分一次性的減值損失將在第四季入賬。另外,公司將其456億元債務從港元和歐元兌換成人民幣,令平均債務成本降至3.5%,節省利息成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.